ClinicalTrials.Veeva

Menu

Precision Analytic Research Methods in OCD

Mount Sinai Health System logo

Mount Sinai Health System

Status

Enrolling

Conditions

Obsessive Compulsive Disorder

Treatments

Behavioral: Exposure and Response Prevention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07011901
STUDY-24-01125
K23MH133997 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Psychiatric disorders characterized by compulsivity, such as obsessive-compulsive disorder (OCD), result in considerable functional impairment and many individuals do not respond to gold-standard treatments. Compulsivity has long been thought to occur due to exaggerated habits and reduced goal-directed control, although more recently, this conceptualization of compulsivity as an imbalance of two cognitive systems has been challenged as overly narrow. This study will recruit 100 individuals (50 adults diagnosed with OCD, 50 healthy controls) and leverage the measurement precision offered by theory-driven computational modeling in combination with electroencephalogram (EEG) to go beyond this binary theory of compulsivity, revealing how more complex interactions of neurocognitive subcomponents contribute to compulsivity-information that could ultimately lead to improved treatment personalization and clinical outcomes.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Participants must be:

  • between the ages 18-55 years old
  • English-speaking
  • right-handed
  • able to provide consent

Exclusion criteria

Individuals diagnosed with OCD will be excluded if:

  • they meet diagnostic criteria for certain other psychiatric disorders
  • are taking psychiatric medication or have received behavioral treatment for OCD within a certain timeframe
  • if it is unsafe for them to participate in research

Healthy control participants will be excluded if:

  • they have a current psychiatric disorder
  • a lifetime history of certain psychiatric disorders
  • are taking psychiatric medication or have in the past
  • have a parent or sibling who has been diagnosed with OCD
  • if it is unsafe for them to participate in research

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Participants diagnosed with OCD
Experimental group
Description:
All participants diagnosed with Obsessive Compulsive Disorder (OCD) who enroll in this study will receive 17 sessions of exposure and response prevention, a specialized cognitive behavioral therapy for OCD, over the course of 10 weeks.
Treatment:
Behavioral: Exposure and Response Prevention
Healthy controls
No Intervention group
Description:
Individuals who do not have a current or lifetime psychiatric diagnosis will not receive any treatment.

Trial contacts and locations

1

Loading...

Central trial contact

Amy Rapp, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems